Proteomika Overview
- Founded
- 2002
- Status
- Acquired/Merged
- Employees
- 5
- Latest Deal Type
- M&A
Proteomika General Information
Description
Provider of biomarkers designed for non-invasive diagnosis of complex diseases. The company's biomarkers are diagnostic assays that offers individualized optimization of treatment regimes by measuring drug response, such as drug bioavailability and immunogenicity.
Contact Information
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Acquirer
Primary Office
- Parque Tecnológico de Bizkaia 504
- 48160 Derio
- Spain
+34 944 00 00 00
Proteomika Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Jan-2015 | Completed | Generating Revenue | |||
| 1. Seed Round | 10-Apr-2004 | Completed | Startup |
Proteomika Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Laureano Simón Ph.D | Chief Executive Officer | ||
| Antonio Martínez Ph.D | Chief Operating Officer |
Proteomika Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialProteomika Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Bizkaia Seed Capital | Venture Capital | Minority | 000 0000 | 000000 0 |